Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01937559 · ClinicalTrials.gov registry record · Phase 4
Topical Tranexamic Acid (TXA) in Joint Arthroplasty
A Phase 4 study, sponsored by The Hawkins Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 188
- Enrollment target
NCT01937559 is a Phase 4 study that has completed, run by The Hawkins Foundation. The registered enrollment target is 188 participants.
The verdict
NCT01937559, a Phase 4 study, has completed, sponsored by The Hawkins Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 188 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the efficacy of topical tranexamic acid (TXA) in decreasing blood loss following both shoulder arthroplasty and primary total hip arthroplasty. TXA functions to decrease blood loss by affecting the blood clotting system within the body. The investigators hypothesize that topical application of TXA prior to closure reduces postoperative bleeding as measured by absolute changes in postoperative hemoglobin levels and surgical drain output. In addition, use of topically applied tranexamic acid may reduce the need for transfusions, the rates of hematomas, infections, and length of hospital stay.
Interventions
- DRUG Normal saline
- BIOLOGICAL Tranexamic acid (TXA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01937559
The ClinicalTrials.gov registry entry for NCT01937559 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Hawkins Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT01937559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01937559 about?
NCT01937559 is a clinical study titled "Topical Tranexamic Acid (TXA) in Joint Arthroplasty". The objective of this study is to evaluate the efficacy of topical tranexamic acid (TXA) in decreasing blood loss following both shoulder arthroplasty and primary total hip arthroplasty. TXA functions to decrease blood loss by affecting the blood clotting system within the body. The investigators hy...
What is the current status of trial NCT01937559?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 188 participants. The study started on 2013-04. Estimated completion is 2018-11.
What interventions are being tested in trial NCT01937559?
The interventions under investigation include: Normal saline (DRUG), Tranexamic acid (TXA) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01937559?
This trial is sponsored by The Hawkins Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.